Arthur F. Kavanaugh

The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh et al. · Arthritis & Rheumatism · 2005 · 1.8K citations

Medicine, Pharmacology, Pharmacotherapy +17

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial

Edward Keystone, Arthur F. Kavanaugh, John T. Sharp et al. · Arthritis & Rheumatism · 2004 · 1.2K citations

Life Sciences, Immunology, Pharmacotherapy +17

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

Arthur F. Kavanaugh, Laurie S. Davis, Lisa Nichols et al. · Arthritis & Rheumatism · 1994 · 264 citations

Life Sciences, Immunology, Pharmacotherapy +17

The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus

Elizabeth W. Karlson, Lawren H. Daltroy, Robert Lew et al. · Arthritis & Rheumatism · 1997 · 226 citations

Pharmacy, Health Sciences, Outcomes Research +16

Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double‐blind, placebo‐controlled trial

Dinesh Khanna, Philip J. Clements, Daniel E. Fürst et al. · Arthritis & Rheumatism · 2009 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8